Related Experiment Video
Updated: Jun 18, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Target genes suitable for silencing approaches and protein product interference in ovarian epithelial cancer
Anastasia Malek1, Reinhold Schäfer, Oleg Tchernitsa
1Institute of Pathology, Charité Universitätsmedizin Berlin, Germany.
Abstract:
Gene expression profiling studies and conventional approaches for the identification of genes involved in the initiation and progression of ovarian cancer have identified a plethora of potential therapeutic targets. This review summarizes the targets that show promise for specific interference in cancer cells, groups them according to their subcellular localization and involved biological processes and discusses their impact on experimental, pre-clinical and clinical therapy.
Insights
Researchers reviewed gene expression profiling and conventional methods to find ovarian cancer therapeutic targets. This summary focuses on promising targets for cancer cell interference, their biological roles, and therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ovarian cancer initiation and progression involve complex genetic alterations.
- Gene expression profiling and conventional methods have identified numerous potential therapeutic targets.
- Targeted therapies offer promise for specific interference in cancer cells.
Purpose of the Study:
- To review and summarize promising therapeutic targets for ovarian cancer.
- To categorize identified targets based on subcellular localization and biological processes.
- To discuss the impact of these targets on experimental, pre-clinical, and clinical therapy.
Main Methods:
- Literature review of gene expression profiling studies.
- Analysis of conventional gene identification approaches.
- Categorization of therapeutic targets by subcellular localization and biological function.
- Evaluation of therapeutic impact across different stages of research and treatment.
Main Results:
- Identification of a plethora of potential therapeutic targets for ovarian cancer.
- Grouping of targets based on their subcellular localization and involvement in key biological processes.
- Discussion of the therapeutic potential and impact of these targets in various research and clinical settings.
Conclusions:
- Numerous promising therapeutic targets for ovarian cancer have been identified.
- Understanding target localization and function is crucial for developing effective therapies.
- These targets hold significant potential for advancing ovarian cancer treatment strategies.
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
